Boehringer Ingelheim Initiates Phase III Clinical Trial With Novel Oral Agent In Adva

[News]

Boehringer Ingelheim announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer...

More... (http://mnt.to/f/3K2M)

[Rich66]

I figured this was a weight loss med. Sounds encouraging..another oral HER tool.